Davis's Drug Guide
betibeglogene autotemcel
General
Pronunciation:
be-ti-beg-loe-geen aw-toe-tem-sel
Trade Name(s)
- Zynteglo
Ther. Class.
temporary class
autologous gene therapyThere's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Betibeglogene Autotemcel." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. www.drugguide.com/ddo/view/Davis-Drug-Guide/3580161/all/betibeglogene_autotemcel.
Vallerand AHA, Sanoski CAC. Betibeglogene autotemcel. Davis's Drug Guide. F.A. Davis Company; 2026. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580161/all/betibeglogene_autotemcel. Accessed August 25, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Betibeglogene autotemcel. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580161/all/betibeglogene_autotemcel
Vallerand AHA, Sanoski CAC. Betibeglogene Autotemcel [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 August 25]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580161/all/betibeglogene_autotemcel.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - betibeglogene autotemcel
ID - 3580161
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/3580161/all/betibeglogene_autotemcel
PB - F.A. Davis Company
ET - 20
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -